CSI Market
Sign In | Register

Ayala Pharmaceuticals Inc (ADXS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ADXS Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Ayala Pharmaceuticals Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent4.88
Short-term Investments, Total0.00
Other Short-term Investments0.00
Cash & Short-term Investments4.00
Accounts receivable0.00
Prepaid Expense And Other Assets Current2.65
Total Current Assets7.53
Equipment/Property/Plant Net0.54
Goodwill net4.50
Intangible Assets0.00
Tax Assets, Noncurrent0.00
Deferred Costs, Noncurrent AS0.00
Other Assets, Noncurrent4.01
Operating Lease Right Of Use Asset0.10
Total Assets16.58
Liabilities
Accounts Payable and Accrued Liabilities, Current LI5.55
Employee-related Liabilities, Current AC0.79
Other Liabilities, Current16.91
Unrecognized Tax Benefits1.77
Total Current Liabilities25.02
Convertible Debt, Noncurrent LO8.14
Total Long-term Debt8.14
Deferred Tax Liabilities, Investments0.00
Accrued Rent, Noncurrent0.00
Operating Lease Liability Current0.17
Proceed From Asset Deal Current4.00
Operating Lease Liability Noncurrent0.01
Long Term Warrant Liability6.06
Total Liabilities33.16
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock172.80
Retained Earnings / Accumulated Deficit-197.23
Other Equity0.00
Common Stockholder's Equity-24.42
Total Stockholder's Equity-24.42
Liabilities & Stockholder's Equity16.58
4 historic quarters locked

Sign in to unlock the full Ayala Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Ayala Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: April 16, 2024
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-24-014822

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.